During 2020, national treatment targets were suspended in recognition of the necessary response to the covid-19 pandemic, before being reinstated in 2021.

We know that the covid-19 pandemic had a major impact across our health services, including the detection and treatment of Hepatitis C. In considering the re-instatement of Hepatitis C treatment targets, both the impact of COVID and associated steps to manage it were considered by the SHPN Hepatitis C Elimination Group, which comprises clinical expertise from Scottish Health Boards.

A recent PHS report shows that the number of new diagnoses made in 2020 and 2021 were the lowest recorded in the last decade. Encouragingly, however, it also shows that major progress has been made despite the pandemic. For example, there is evidence to indicate that Scotland has already achieved one of the WHO targets set for 2030; 80% of those ever diagnosed having received treatment.

The full PHS report can be found here: Surveillance of hepatitis C in Scotland (publichealthscotland.scot).

The NHS in Scotland has a strong track record of delivering innovative sexual health and blood borne virus services.

For example, in 2017, Scotland was one of the first countries in the world to introduce an HIV Pre-Exposure Prophylaxis service - offering free preventative medication to those deemed at highest risk of acquiring HIV.

To ensure we build on this progress, in December 2022, the Scottish Government committed to support a pilot for an online service providing access to PrEP. Work on this is now being taken forward.

The Scottish Government has also committed to improving testing for sexual health and blood borne viruses, to ensure more people can receive the treatment they need. We have funded a home-testing HIV pilot project run by HIV Scotland to help evaluate the viability of this approach and its scope to increase parity of access in remote and rural areas. We have also provided over £0.5m for the development of a “once for Scotland” approach to STI home testing. This was rolled out in NHS Lothian in December, and work is underway to explore further roll-out. This service allows people to request a test online and perform home self-sampling, while providing clinicians with comprehensive, real-time data.

We recognise that the development of new models of service and treatment is an ongoing, iterative process. The Scottish Government will continue to support this, including through development of the next Sexual Health and Blood Borne Viruses Framework.

Establishing a Women’s Health Lead in every board is a medium term action in the Women’s Health Plan due for delivery by September 2024 . NHS Boards have begun the process of identifying their Women’s Health Lead.

The Scottish Government is committed to ensuring women can access appropriate contraception when and where they need it. Since November 2021, community pharmacies have been able to supply the progestogen-only pill for a 3-month period, if clinically appropriate to do so, and in line with a national Patient Group Direction (PGD). The national roll-out followed a successful pilot in pharmacies across Lothian and Tayside.

This availability of bridging contraception from community pharmacies enables women to access contraception without the need for a prescription and receive healthcare advice and treatment from their community pharmacist. Thereafter, individuals wishing to continue with a regular supply or access an alternative method of contraception, may contact their GP practice to request a repeat prescription or request an appointment to discuss their options.

Contraception can be obtained for free from:

• most GP surgeries

• community contraception clinics

• some genitourinary medicine (GUM) clinics

• sexual health clinics

• some young people's services.

However, there are two brands of the progestogen-only available to purchase over the counter (OTC) in pharmacies, increasing choice for women in the ways in which they can access contraception.

Yes. The platform can be found at : Women's health | NHS inform

The Women’s Health Plan, published in August 2021, contains an action to implement a Women’s Health Service in community pharmacies.

This service will be introduced on an incremental basis over the next few years. The first step was the introduction of bridging contraception in community pharmacies from November 2021.

There are a number of ways that good practice, clinical updates and learning on women’s health are shared across primary care. Examples of this include:

• Regular women’s health update days for primary care held at both board and national level.
• Regular training and updates for a range of women’s services, including perinatal care, smear taking, long acting contraception insertion and removal, and the menopause.
• Working with pharmacy colleagues on ensuring up-to-date and relevant prescribing information is available.
• Primary care engagement through local interface groups in developing local pathways and protocols for women’s health.
• Dissemination of updated guidelines on women’s health from areas such as SIGN, NICE and Royal Colleges through local distribution networks, signposting to new, relevant publications such as the Women’s Health Plan.
• Supporting shared learning around good practice through initiatives such as funding for first 5 GPs to attend local, problem-based small learning groups.

Additionally, locally and nationally driven learning through innovative practice is shared via primary and secondary care networks. Examples of this include:

• Increasing cervical screening uptake through using enhanced engagement techniques targeting opportunistic and vulnerable groups.
• Learning from recent trials of group education and group consultations on menopause at general practice level.
• The National Menopause Specialist Network, where examples of innovative practice across primary and secondary care are regularly shared.

Sharing good practice will be an ongoing piece of work throughout the lifetime of the Women’s Health Plan.

Data is only available from 2015-16. Since 2015-16 a total of 1,531 pharmacist trainees have stayed in Scotland to complete their pre-registration training year.

The following table shows number of pharmacist trainees who have stayed in Scotland to complete their registration broken down for each year since 2015-16.

An expert Menopause and Menstrual Health Policy Working Group has been established to progress this action.

Work is currently underway in the Scottish Public Health Workforce Development Group to assess needs and agree priority actions in relation to the public health workforce, taking into account previous recommendations and learning from the pandemic. The Public Health Scotland (PHS) and Scottish Directors of Public Health Localised Working Programme is currently working with three pathfinder sites to improve local access to specialist public health advice and forms a collaboration between PHS, local health boards and joint partners, including COSLA. The programme aims to achieve better outcomes for communities through leading and supporting action on inequalities and the determinants of health.

A recent review of the Scottish Health Protection Network has also identified learning from the pandemic and considered how to ensure a strengthened health protection function for Scotland going forward.